Analyst Consensus ?
ConsensusHold28 ratings
Bullish1242.9%
Neutral1657.1%
Bearish00.0%
FN2 Earnings Intelligence
Invesco Ltd. complete analyst coverage
Invesco Ltd. (IVZ) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$31.71Current
$17Low
$28.67Average
$39High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Evercore ISI Group | In Line | In Line | Maintain | Sep 9, 2026 |
| TD Cowen | Buy | Buy | Maintain | Aug 13, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Jul 29, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 29, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Jul 17, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Apr 29, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 10, 2026 |
| Argus Research | Buy | Buy | Maintain | Jan 28, 2026 |
| Deutsche Bank | Buy | Hold | Upgrade | Dec 17, 2025 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 2, 2025 |
| Citigroup | Neutral | Neutral | Maintain | Sep 29, 2025 |
| Wells Fargo | Equal Weight | Underweight | Upgrade | Jul 11, 2025 |
| UBS | Neutral | Neutral | Maintain | Feb 3, 2025 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Jan 29, 2025 |
| Credit Suisse | Neutral | Underperform | Upgrade | Mar 29, 2023 |
| Jefferies | Hold | Buy | Downgrade | Jun 7, 2019 |
| Keefe Bruyette & Woods | Market Perform | Outperform | Downgrade | Jul 13, 2018 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Bank of America | Neutral | Buy | Downgrade | Jan 8, 2018 |
| Keefe, Bruyette& Woods | Perform | Outperform | Downgrade | Dec 12, 2016 |
| Susquehanna | Positive | Positive | Maintain | Sep 3, 2015 |
| PiperJaffray | Overweight | Overweight | Maintain | Jun 3, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Jan 7, 2015 |
| Evercore Partners | Equal Weight | Equal Weight | Maintain | Jul 10, 2013 |
| Nomura | Buy | Buy | Maintain | May 1, 2013 |
| Stifel Nicolaus | Buy | Buy | Maintain | Feb 1, 2013 |
| Stifel | Buy | Buy | Maintain | Feb 1, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $31.71. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Analyst unavailable | $39 | $32.02 | +23.0% | Aug 13, 2026 |
| Evercore ISI | Analyst unavailable | $35 | $32.05 | +10.4% | Aug 10, 2026 |
| Barclays | Analyst unavailable | $32 | $29.43 | +0.9% | Jul 29, 2026 |
| Barclays | Analyst unavailable | $31 | $28.4 | -2.2% | Jul 14, 2026 |
| Evercore ISI | Analyst unavailable | $32 | $29.08 | +0.9% | Jul 10, 2026 |
| Evercore ISI | Analyst unavailable | $31 | $27.79 | -2.2% | Jun 8, 2026 |
| Goldman Sachs | Alexander Blostein | $30 | $25.88 | -5.4% | Apr 29, 2026 |
| Barclays | Analyst unavailable | $26 | $25.88 | -18.0% | Apr 29, 2026 |
| RBC Capital | Kenneth Lee | $31 | $24.95 | -2.2% | Apr 21, 2026 |
| Evercore ISI | Analyst unavailable | $27 | $23.63 | -14.9% | Apr 10, 2026 |
| BMO Capital | Analyst unavailable | $28 | $23.63 | -11.7% | Apr 10, 2026 |
| RBC Capital | Kenneth Lee | $33 | $27.76 | +4.1% | Jan 28, 2026 |
| Cowen & Co. | Analyst unavailable | $34.5 | $27.28 | +8.8% | Jan 28, 2026 |
| Argus Research | Stephen Biggar | $31 | $27.26 | -2.2% | Jan 28, 2026 |
| Goldman Sachs | Analyst unavailable | $29.5 | $27.16 | -7.0% | Jan 28, 2026 |
| Barclays | Analyst unavailable | $29 | $27.16 | -8.5% | Jan 28, 2026 |
| Morgan Stanley | Analyst unavailable | $29 | $28.4 | -8.5% | Jan 26, 2026 |
| RBC Capital | Kenneth Lee | $35 | $28.95 | +10.4% | Jan 21, 2026 |
| Goldman Sachs | Alexander Blostein | $28.75 | $28.25 | -9.3% | Jan 15, 2026 |
| Barclays | Benjamin Budish | $30 | $28.25 | -5.4% | Jan 15, 2026 |
| Goldman Sachs | Alexander Blostein | $28.25 | $28.16 | -10.9% | Jan 6, 2026 |
| Morgan Stanley | Analyst unavailable | $28 | $26.82 | -11.7% | Dec 17, 2025 |
| Deutsche Bank | Analyst unavailable | $31 | $26.03 | -2.2% | Dec 17, 2025 |
| Barclays | Benjamin Budish | $28 | $26.99 | -11.7% | Dec 12, 2025 |
| BMO Capital | Analyst unavailable | $30 | $26.54 | -5.4% | Dec 10, 2025 |
| Goldman Sachs | Analyst unavailable | $25.5 | $23.81 | -19.6% | Nov 25, 2025 |
| Fundamental Research | Analyst unavailable | $27 | $23.66 | -14.9% | Oct 31, 2025 |
| RBC Capital | Kenneth Lee | $25 | $24.02 | -21.2% | Oct 30, 2025 |
| Goldman Sachs | Analyst unavailable | $26.5 | $24.35 | -16.4% | Oct 29, 2025 |
| Barclays | Analyst unavailable | $24 | $22.84 | -24.3% | Oct 21, 2025 |
| Morgan Stanley | Analyst unavailable | $26 | $23.98 | -18.0% | Oct 6, 2025 |
| Evercore ISI | Glenn Schorr | $24 | $21.99 | -24.3% | Sep 5, 2025 |
| Wells Fargo | Michael Brown | $18 | $17.43 | -43.2% | Jul 11, 2025 |
| Barclays | Benjamin Budish | $19 | $18.04 | -40.1% | Oct 23, 2024 |
| Wells Fargo | Michael Brown | $16 | $15.8 | -49.5% | Sep 11, 2024 |
| RBC Capital | Kenneth Lee | $16 | $14.52 | -49.5% | Apr 25, 2024 |
| Deutsche Bank | Brian Bedell | $17 | $16.53 | -46.4% | Apr 5, 2024 |
| Morgan Stanley | Analyst unavailable | $23 | $18.96 | -27.5% | Apr 27, 2022 |
| Deutsche Bank | Brian Bedell | $24 | $19.03 | -24.3% | Apr 27, 2022 |
| Morgan Stanley | Analyst unavailable | $25 | $20.39 | -21.2% | Apr 25, 2022 |
| RBC Capital | Kenneth Lee | $23 | $21.41 | -27.5% | Jan 24, 2022 |
| Barclays | Jeremy Campbell | $25 | $26.29 | -21.2% | Apr 30, 2021 |
| Argus Research | Stephen Biggar | $33 | $26.51 | +4.1% | Apr 28, 2021 |
| Wells Fargo | Christopher Harris | $25 | $25.23 | -21.2% | Apr 13, 2021 |
Track every rating change on IVZ the moment it posts. Free to start.
Start free